The Alzheimer’s Economy: Is the New $56,000-a-Year Drug Worth It?
The potential costs go well beyond just the medicine. The exigencies of administering it look set to challenge established patterns of caring for those with dementia, creating a need for different kinds of staff and expensive equipment not typically associated with treating the disease.
The cost of the intravenous infusion of the medicine, radiology and imaging could add between $2,000 and $15,000 or even more on top of the drug’s price tag, according to estimates from Premier, a group that represents more than 4,000 US hospitals.
